Location: Los Angeles, CA
CIK: 0001969764 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 14, 2026
Total Value: $159M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PAGP | PLAINS GP HLDGS L P | 1,272,360 | $30.18M | 19.0% | $18.82 | — | LTD PARTNR INT A | 72651A207 |
| ACHV | ACHIEVE LIFE SCIENCES INC | 3,786,425 | $11.37M | 7.2% | $3.48 | +37.1% | COM | 004468500 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 841,272 | $9.354M | 5.9% | $10.51 | +30.4% | COM | 71722W107 |
| DCTH | DELCATH SYS INC | 979,698 | $9.159M | 5.8% | $11.14 | -10.3% | COM NEW | 24661P807 |
| CORT | CORCEPT THERAPEUTICS INC | 147,828 | $6.022M | 3.8% | $38.80 | 0.0% | COM | 218352102 |
| ABEO | ABEONA THERAPEUTICS INC | 1,329,899 | $6.008M | 3.8% | $5.26 | -1.7% | COM NEW | 00289Y206 |
| VOR | VOR BIOPHARMA INC | 314,543 | $5.587M | 3.5% | $13.98 | 0.0% | COM NEW | 929033207 |
| KYTX | KYVERNA THERAPEUTICS INC | 644,421 | $5.586M | 3.5% | $7.42 | +11.8% | COM | 501976104 |
| MIST | MILESTONE PHARMACEUTICALS IN | 4,118,321 | $5.082M | 3.2% | $1.80 | +5.5% | COM | 59935V107 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 131,364 | $4.135M | 2.6% | $23.17 | +9.7% | COM NEW | 15117B202 |
| CMPS | COMPASS PATHWAYS PLC | 742,049 | $4.118M | 2.6% | $6.21 | — | SPONSORED ADS | 20451W101 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 210,163 | $4.088M | 2.6% | $24.44 | +26.2% | COM | 92790C104 |
| IVA | INVENTIVA SA | 724,678 | $3.995M | 2.5% | $4.65 | — | ADS | 46124U107 |
| SABS | SAB BIOTHERAPEUTICS INC | 1,012,790 | $3.886M | 2.4% | $3.54 | +12.9% | COM NEW | 78397T202 |
| OBIO | ORCHESTRA BIOMED HLDGS INC | 896,701 | $3.831M | 2.4% | $4.12 | 0.0% | COM | 68572M106 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 380,420 | $3.581M | 2.3% | $8.57 | 0.0% | COM | 35104E100 |
| OCS | OCULIS HOLDING AG | 122,223 | $3.279M | 2.1% | $20.00 | +32.4% | ORDINARY SHARES | H5870P102 |
| OCUL | OCULAR THERAPEUTIX INC | 382,375 | $3.226M | 2.0% | $9.83 | 0.0% | COM | 67576A100 |
| UPB | UPSTREAM BIO INC | 341,779 | $3.1M | 2.0% | $23.68 | 0.0% | COM | 91678A107 |
| AQST | AQUESTIVE THERAPEUTICS INC | 710,988 | $2.951M | 1.9% | $4.02 | 0.0% | COM | 03843E104 |
| EYPT | EYEPOINT INC | 215,825 | $2.789M | 1.8% | $15.22 | 0.0% | COM NEW | 30233G209 |
| TRVI | TREVI THERAPEUTICS INC | 223,802 | $2.647M | 1.7% | $10.94 | 0.0% | COM | 89532M101 |
| ZVRA | ZEVRA THERAPEUTICS INC | 282,418 | $2.641M | 1.7% | $8.38 | +4.5% | COM NEW | 488445206 |
| IMUX | IMMUNIC INC | 2,344,779 | $2.62M | 1.7% | $0.72 | 0.0% | COM | 4525EP101 |
| CHRS | COHERUS ONCOLOGY INC | 1,420,550 | $2.413M | 1.5% | $1.82 | 0.0% | COM | 19249H103 |
| OVID | OVID THERAPEUTICS INC | 921,457 | $2.038M | 1.3% | $1.60 | 0.0% | COM | 690469101 |
| PALI | PALISADE BIO INC | 1,115,000 | $1.997M | 1.3% | $1.78 | 0.0% | COM | 696389402 |
| KLRS | KALARIS THERAPEUTICS INC | 295,771 | $1.721M | 1.1% | $8.95 | +4.7% | COM | 482929106 |
| QURE | UNIQURE NV | 104,772 | $1.713M | 1.1% | $23.55 | 0.0% | SHS | N90064101 |
| LONA | LEONABIO INC | 149,279 | $1.496M | 0.9% | $3.92 | +43.4% | COM | 04746L203 |
| NUVB | NUVATION BIO INC | 329,296 | $1.413M | 0.9% | $6.19 | 0.0% | COM CL A | 67080N101 |
| MAZE | MAZE THERAPEUTICS INC | 43,798 | $1.307M | 0.8% | $44.04 | 0.0% | COM | 578784100 |
| EVMN | EVOMMUNE INC | 55,664 | $1.28M | 0.8% | $21.99 | 0.0% | COM SHS | 30054Y107 |
| CRVS | CORVUS PHARMACEUTICALS INC | 85,791 | $1.251M | 0.8% | $16.29 | 0.0% | COM | 221015100 |
| ALDX | ALDEYRA THERAPEUTICS INC | 730,606 | $1.235M | 0.8% | $4.96 | 0.0% | COM | 01438T106 |
| ARTV | ARTIVA BIOTHERAPEUTICS INC | 146,369 | $950K | 0.6% | $4.41 | 0.0% | COM | 04317A107 |
| CNTB | CONNECT BIOPHARMA HLDGS LTD | 209,493 | $554K | 0.3% | $2.48 | 0.0% | SHS | G23549101 |
| MSLE | SATELLOS BIOSCIENCE INC | 10,145 | $57,116 | 0.0% | $5.63 | — | COM | 80401L803 |